JPRN-UMIN000002124尚未招募未知
Screening of cyromegalovirus infection in pregnant women and prevention of congenital cytomegalovirus infection of fetuses - cyromegalovirus infection in pregnant women and prevention of congenital cytomegalovirus infection
Kobe University Graduate School of Medicine, Department of Obstetrics and Gynecology0 个研究点目标入组 1,200 人开始时间: 2009年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •pregnant women not infected with CMV
研究者
相似试验
已完成
不适用
Screening for cytomegalovirus in pregnant womecytomegalovirus infectionJPRN-UMIN000012607Kobe University2,000
招募中
不适用
Tests of cytomegalovirus fetomaternal infectioCytomegalovirus fetomaternal infectionJPRN-UMIN000020055Mie University30
招募中
不适用
Targeted Screening for Congenital Cytomegalovirus-related Hearing loss in infants in Western AustraliaCongenital CMV-related Hearing LossEar - DeafnessInfection - Other infectious diseasesACTRN12621000484842Dr Jafri Kuthubutheen140
招募中
不适用
A target screening for congenital cytomegalovirus infection in pregnant women and newbornsCongenital cytomegalovirus infectionJPRN-UMIN000045977Teine Keijinkai Hospital2,000
进行中（未招募）
1 期
Traitement prénatal de l'infection congénitale à cytomégalovirus par le letermovir randomisé contre le valaciclovirStep 1: Maternal administration of 1 tablet of Letermovir (240 mg or 480 mg /day) during 3 days before TOPStep 2: Maternal daily administration of 240 or 480 milligrams of letermovir (1x240 mg-tablets) or (1x480 mg-tablets) (the dose will be choosen depending on the results obtained on step 1) up-until delivery or TOPEUCTR2020-002924-35-FRASSISTANCE PUBLIQUE HÔPITAUX DE PARIS56